Dana-Farber initiative will require pre-emptive genetic testing before 5-FU and/or capecitabine
Under a new Dana-Farber initiative, patients due to receive either [...]
NCODA publishes a Positive Quality Intervention recommending screening for DPD/DPYD prior to the use of fluoropyrimidine based chemotherapy
The National Community Oncology Dispensing Association (NCODA) mission is to [...]
